HKDC1 and neoplasm: Patients with elevated levels of HKDC1 exhibited reduced immune scores and stromal scores, indicating that HKDC1 overexpression hampers the infiltration of immune cells in pancreatic cancer, thereby impeding its anti-tumor effects.